GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Optigenex Inc (OTCPK:OPGX) » Definitions » Capex-to-Revenue

Optigenex (Optigenex) Capex-to-Revenue : 0.00 (As of Jun. 2008)


View and export this data going back to 2004. Start your Free Trial

What is Optigenex Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Optigenex's Capital Expenditure for the three months ended in Jun. 2008 was $0.00 Mil. Its Revenue for the three months ended in Jun. 2008 was $0.18 Mil.

Hence, Optigenex's Capex-to-Revenue for the three months ended in Jun. 2008 was 0.00.


Optigenex Capex-to-Revenue Historical Data

The historical data trend for Optigenex's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optigenex Capex-to-Revenue Chart

Optigenex Annual Data
Trend Dec04 Dec05 Dec06 Dec07
Capex-to-Revenue
0.65 0.23 0.15 -

Optigenex Quarterly Data
Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Optigenex's Capex-to-Revenue

For the Diagnostics & Research subindustry, Optigenex's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optigenex's Capex-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Optigenex's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Optigenex's Capex-to-Revenue falls into.



Optigenex Capex-to-Revenue Calculation

Optigenex's Capex-to-Revenue for the fiscal year that ended in Dec. 2007 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.466
=0.00

Optigenex's Capex-to-Revenue for the quarter that ended in Jun. 2008 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.183
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optigenex  (OTCPK:OPGX) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Optigenex Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Optigenex's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Optigenex (Optigenex) Business Description

Traded in Other Exchanges
N/A
Address
901 Sam Rayburn Highway, Melissa, TX, USA, 75454
Optigenex Inc is an applied sciences company dedicated to solutions for healthy age management. The company offers AC-11, a powdered and bioactive rainforest plant extract that helps the body to repair sun and environmental stress-related damage to DNA, and slow down the process of skin aging.
Executives
Richard S Serbin director, 10 percent owner, officer: CEO, President & Secretary 750 LEXINGTON AVENUE, 6TH FLOOR, NEW YORK NY 10022

Optigenex (Optigenex) Headlines

No Headlines